Ryan D. Chavez
Keine laufenden Positionen mehr
Karriereverlauf von Ryan D. Chavez
Ehemalige bekannte Positionen von Ryan D. Chavez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ASTERIAS BIOTHERAPEUTICS INC | Finanzdirektor/CFO | 17.11.2016 | 01.03.2019 |
General Counsel | 18.07.2016 | 01.03.2019 | |
Unternehmenssekretär | 18.07.2016 | 01.03.2019 | |
QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
MALLINCKRODT PLC | General Counsel | - | - |
Rutan & Tucker LLP
Rutan & Tucker LLP Miscellaneous Commercial ServicesCommercial Services Rutan & Tucker LLP provides legal services. It offers corporate and tax, employment, intellectual property, litigation and trial, and real estate services. The company was founded in 1986 and is headquartered in Costa Mesa, CA. | Corporate Officer/Principal | 02.05.2011 | - |
Ausbildung von Ryan D. Chavez
Chapman University | Graduate Degree |
Stanford University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Irland | 2 |
Operativ
Corporate Officer/Principal | 2 |
General Counsel | 2 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MALLINCKRODT PLC | Health Technology |
Private Unternehmen | 3 |
---|---|
Rutan & Tucker LLP
Rutan & Tucker LLP Miscellaneous Commercial ServicesCommercial Services Rutan & Tucker LLP provides legal services. It offers corporate and tax, employment, intellectual property, litigation and trial, and real estate services. The company was founded in 1986 and is headquartered in Costa Mesa, CA. | Commercial Services |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
- Börse
- Insiders
- Ryan D. Chavez
- Erfahrung